Valproate attenuates dextroamphetamine-induced subjective changes more than lithium

European Neuropsychopharmacology

Volumn 15, Issue 6, 2005, Pages 633-639

  Willson, Morgan C ^a   Bell, Emily C ^a   Dave, Sanjay ^a   Asghar, Sheila J ^a   McGrath, Brent M ^a   Silverstone, Peter H ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dextroamphetamine; Human volunteers; Lithium; Sodium valproate

Indexed keywords

DEXAMPHETAMINE; LITHIUM; PLACEBO; VALPROIC ACID;

ADULT; ALERTNESS; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; ENERGY; FEMALE; HAPPINESS; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AFFECT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LITHIUM; MALE; MIDDLE AGED; VALPROIC ACID;

EID: 27744521375     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2005.04.015     Document Type: Article

References (46)

1. B. Angrist, and S. Gershon Variable attenuation of amphetamine effects by lithium Am. J. Psychiatry 136 1979 806 810
2. B. Angrist, J. Corwin, B. Bartlik, and T. Cooper Early pharmacokinetics and clinical effects of oral dextroamphetamine in normal subjects Biol. Psychiatry 22 1987 1357 1368
3. S.J. Asghar, A.M. Veronique, M.I. Tanay, G.B. Baker, A. Greenshaw, and P.H. Silverstone Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteer Hum. Psychopharmacol. Clin. Exp. 18 2003 291 299
4. C.G. Aylmer, H. Steinberg, and R.A. Webster Hyperactivity induced by dexamphetamine/chlordiazepoxide mixtures in rats and its attenuation by lithium pretreatment: a role for dopamine? Psychopharmacology (Berl.) 91 1987 198 206
5. A.I. Barkai Myo-inositol turnover in the intact rat brain: increased production after d-amphetamine J. Neurochem. 36 1981 1485 1491
6. M.J. Berridge, and R.F. Irivine Inositol phosphates and cell signalling Nature 341 1989 197 205
7. M. Berridge, C.P. Downes, and M.R. Hanley Neural and developmental actions of lithium: a unifying hypothesis Cell 59 1989 411 419
8. L.H. Brauer, and H. de Wit Subjective responses to dextroamphetamine alone and after pimozide pretreatment in normal, healthy volunteers Biol. Psychiatry 39 1996 26 32
9. L.H. Brauer, and H. de Wit High dose pimozide does not block amphetamine-induced euphoria in normal volunteers Pharmacol. Biochem. Behav. 56 1997 265 272
10. B.J. Cao, and N.A. Peng Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents Eur. J. Pharmacol. 237 1993 177 181
11. P. Cappeliez, and E. Moore Effects of lithium on an amphetamine animal model of bipolar disorder Prog. Neuro-psychopharmacol. Biol. Psychiatry 14 1990 347 358
12. C.S. Dommisse, S.C. Schulz, N. Narasimhachari, W.G. Blackard, and R.M. Hamer The neuroendocrine and behavioral response to dextroamphetamine in normal individuals Biol. Psychiatry 19 1984 1305 1315
13. J.E. Fabian, and P.H. Silverstone Diltiazem, a calcium antagonist, partly attenuates the effects of dextroamphetamine in healthy volunteers Int. Clin. Psychopharmacol. 12 1997 113 120
14. M.W. Fischman, and R.W. Foltin Utility of subjective effects measurements in assessing abuse liability of drugs in humans Br. J. Addict 86 1991 1563 1570
15. S.K. Fisher, A.M. Heacock, and B.W. Agranoff Inositol lipids and signal transduction in the nervous system: an update J. Neurochem. 58 1992 18 38
16. A. Flemenbaum Does lithium block the effects of amphetamine? A report of three cases Am. J. Psychiatry 131 1974 820 821
17. F. Fogarty, J.M. Russell, S.C. Newman, and R.C. Bland Mania Acta Psychiatr. Scand., Suppl. 376 1994 16 23
18. M.F. Folstein, and R. Luria Reliability, validity, and clinical application of the visual analogue mood scale Psychol. Med. 3 1973 479 486
19. F.K. Goodwin, and K.R. Jamison Manic Depressive Illness 1990 Oxford University Press New York
20. T.A. Grady, A. Broocks, S.K. Canter, T.A. Pigott, B. Dubbert, J.L. Hill, and D.L. Murphy Biological and behavioral responses to dextroamphetamine, alone and in combination with the serotonin-3 receptor antagonist ondansetron, in healthy volunteers Psychiatry Res. 64 1996 1 10
21. M.J. Hamilton, P.R. Smith, and A.W. Peck Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers Br. J. Clin. Pharmacol. 15 1983 367 374
22. S. Hernandez-Lopez, T. Tkatch, E. Perez-Garci, E. Galarraga, J. Bargas, H. Hamm, and D.J. Surmeier D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3-calcineurin-signaling cascade J. Neurosci. 20 2000 8987 8995
23. B.G. Hoebel, L. Hernandez, D.H. Schwartz, G.P. Mark, and G.A. Hunter Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications Ann. N.Y. Acad. Sci. 575 1989 171 191 (discussion 192-3)
24. R.M. Izquierdo-Claros, M.C. Boyano-Adanez, C. Larsson, L. Gustavsson, and E. Arilla Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum Brain Res. Mol. Brain Res. 47 1997 99 107
25. D. Jacobs, and T. Silverstone Dextroamphetamine induced arousal in human subjects as a model for mania Psychol. Med. 16 1986 323 329
26. R. Karler, L.D. Calder, L.H. Thai, and J.B. Bedingfield A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine Brain Res. 658 1994 8 14
27. R. Kuczenski, and D.S. Segal An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens J. Neurosci. 17 1997 4441 4447
28. J.S. Markowitz, S.D. Morrison, and C.L. DeVance Drug interactions with psychostimulants Int. Clin. Psychopharmacol. 14 1999 1 18
29. T. O'Donnell, S. Rotzinger, T.T. Nakashima, C.C. Hanstock, M. Ulrich, and P.H. Silverstone Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain Brain Res. 880 2000 84 91
30. R.J. Ralph-Williams, M.P. Paulus, X. Zhuang, R. Hen, and M.A. Geyer Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system Biol. Psychiatry 53 2003 352 359
31. J.L. Rapoport, M.S. Buchsbaum, T.P. Zahn, H. Weingartner, C. Ludlow, and E.J. Mikkelsen Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys Science 199 1978 560 563
32. M.S. Reid, K. Hsu, and S.P. Berger Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine Synapse 27 1997 95 105
33. L.S. Seiden, K.E. Sabol, and G.A. Ricaurte Amphetamine: effects on catecholamine systems and behavior Annu. Rev. Pharmacol. Toxicol. 33 1993 639 677
34. P.H. Silverstone, and L. Birkett Diltiazem as augmentation therapy in patients with treatment-resistant bipolar disorder: a retrospective study J. Psychiatry Neurosci. 25 2000 276 280
35. T. Silverstone, J. Fincham, B. Wells, and M. Kyriakides The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man Neuropharmacology 19 1980 1235 1237
36. T. Silverstone, B. Wells, and E. Trenchard Differential dose-response effects of dexamphetamine sulphate on hunger, arousal and mood in human volunteers Psychopharmacology 79 1983 242 245
37. P.H. Silverstone, B. Johnson, and P.J. Cowen Does ondansetron attenuate dextroamphetamine-induced behavior in human volunteers? Psychopharmacolgy (Berlin) 107 1992 140 141
38. P.H. Silverstone, A. Pukhovsky, and S. Rotzinger Lithium does not attenuate the effects of dextroamphetamine in healthy volunteers Psychiatry Res. 79 1998 219 226
39. P.H. Silverstone, R.H. Wu, T. O'Donnell, M. Ulrich, S.J. Asghar, and C.C. Hanstock Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients Hum. Psychopharmacol. 17 2002 321 327
40. P.H. Silverstone, T. O'Donnell, M. Ulrich, S. Asghar, and C.C. Hanstock Dextroamphetamine increases phosphoinositol cycle activity in volunteers: an MRS study Hum. Psychopharmacol. Clin. Exp. 17 2002 425 429
41. K.Y. Tseng, and P. O'Donnell Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms J. Neurosci. 24 2004 5131 5139
42. L. Vallar, and J. Meldolesi Mechanisms of signal transduction at the dopamine D2 receptor Trends Pharmacol. Sci. 10 1989 74 77
43. D.P. van Kammen, and D.L. Murphy Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment Psychopharmacologia (Berlin) 44 1975 215 224
44. R.S. Williams, L. Cheng, A.W. Mudge, and A.J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295
45. M.F. Yu, W.W. Lin, L.T. Li, and H.S. Yin Activation of metabotropic glutamate receptor 5 is associated with effect of amphetamine on brain neurons Synapse 50 2003 334 344
46. J.P. Zacny, B.K. Bodker, and H. de Wit Effects of setting on the subjective and behavioral effects of d-dextroamphetamine in humans Addict. Behav. 17 1992 27 33